Gonadotropins and prostate cancer: revisited.

Thwaini, Ali, Naase, Mahmoud, Chinegwundon, Frank, Baithun, Suhail, Ghali, Lucy ORCID logoORCID: https://orcid.org/0000-0003-3410-6615, Shergill, Iqbal and Iles, Ray K. (2006) Gonadotropins and prostate cancer: revisited. Urologia internationalis, 77 (4) . pp. 289-296. ISSN 0042-1138 [Article] (doi:10.1159/000096330)


Luteinizing hormone and follicle-stimulating hormone are called gonadotropins, because they stimulate the gonads – in males the testes and in females the ovaries. They are not necessary for life, but are essential for reproduction. In addition, the association of these hormones with prostate cancer has been the interest of many researchers. Their detection in the human prostate has been investigated using different methods, including immunologic and RT-PCR techniques. In addition, the increasing evidence of paracrine/autocrine functions of the gonadotropic glycoprotein hormones, their allocation to the superfamily of cystine knot growth factors, and luteinizing hormone/chorionic gonadotropin receptor gene expression in non-gonadal tissues led many researchers to investigate intraprostatic glycoprotein hormones and their receptor gene expression. We aim in this review to shed light on the physiology of the gonadotropins and their association with prostate cancer and highlight the future possibilities of their use as targets in treating this disease.

Item Type: Article
Research Areas: A. > School of Science and Technology > Natural Sciences > Biomarkers for Cancer group
ISI Impact: 1
Item ID: 2368
Useful Links:
Depositing User: Repository team
Date Deposited: 20 May 2009 09:47
Last Modified: 13 Oct 2016 14:14
URI: https://eprints.mdx.ac.uk/id/eprint/2368

Actions (login required)

View Item View Item


Activity Overview
6 month trend
6 month trend

Additional statistics are available via IRStats2.